Explore

Iterate

Vision

Voyager Therapeutics

Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases.

Industries

Biotechnology, Education

Headquarters

Cambridge, United States

Stage

Series B

Employees

201-500

Links

Org chart

Al Sandrock
CEO
Collapse
Todd Carter
Chief Science Officer
Allen Nunnally
Chief Business Officer
Michelle Quinn Smith
Chief Human Resources Officer
Robin Swartz
COO
Peter Pfreundschuh
CFO
Robert Hesslein
General Counsel
Trista Morrison
SVP, Corporate Affairs

Teams

View all

+3

Leadership Team

6 members

Board of Directors

3 members

+2

CEO and Executive Team

5 members

Discover similar companies

Denali Therapeutics

Series B • South San Francisco, United States

ONI

Series B • San Diego, United States

Korro Bio

Series B • Cambridge, United States

Checkerspot

Series B • Oakland, United States

Goldfinch Bio

Series B • Cambridge, United States

Erasca

Series B • San Diego, United States

TwinStrand Biosciences

Series B • Seattle, United States

Photomath

Series B • San Mateo, United States

Lumos Pharma

Series B • Austin, United States

Sonoma Biotherapeutics

Series B • South San Francisco, United States

Allakos

Series B • San Carlos, United States

Odyssey Therapeutics

Series B • Cambridge, United States

The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.
  • Resources

    AboutSupportCompaniesPeopleTeams
  • Solutions

    Vision - Lead GenPartner with us
  • Iterate

    Tech MovesTop StartupsPeople & CultureOrg DesignGuides
  • Visit us at

    The OrgFacebookTwitter
  • © 2023 Orgio, Inc.
  • Terms
  • Privacy
  • Data